Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

TRACON Pharmaceuticals Q3 EPS $(0.38), Same YoY

TRACON Pharmaceuticals (NASDAQ:TCON) reported quarterly losses of $(0.38) per share. This is unchanged from the same period last year.

byBenzinga Newsdesk

November 3, 2021

1 minute read

TRACON Pharmaceuticals (NASDAQ:TCON) reported quarterly losses of $(0.38) per share. This is unchanged from the same period last year.

Bausch Health Companies Q4 Sales, FY22 Outlook Lag Wall Street View

By Vandana Singh

Today, 1:33 PM

Bausch Health Companies Inc (NYSE: BHC) has reported

BHC

Recap: OFS Capital Q2 Earnings

By Benzinga Insights

Today, 1:33 PM

Shares of OFS Capital (NASDAQ:OFS) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share were up 26.32% year over year to $0.24, which beat the estimate of $0.23.

OFS

Swiss Regulatory Authority Find Credit Suisse In Serious Violation Regarding Greensill Debacle

By Vandana Singh

Today, 1:33 PM

The Swiss Financial Market Supervisory Authority FINMA has concluded its enforcement proceedings against Credit Suisse Group AG (NYSE:CS) concerning its business relationship…

Thinking About Buying Stock In Starbucks, CVS Or Match Group?

By Henry Khederian

Today, 1:33 PM

One of the most common questions traders have about stocks is “Why Is It Moving?”

CVS

TRACON Pharmaceuticals Q3 EPS $(0.38), Same YoY

Related Posts

Bausch Health Companies Q4 Sales, FY22 Outlook Lag Wall Street View

Recap: OFS Capital Q2 Earnings

Swiss Regulatory Authority Find Credit Suisse In Serious Violation Regarding Greensill Debacle

Thinking About Buying Stock In Starbucks, CVS Or Match Group?